Ge Healthcare Technologies INC Schedule 13G passive stakes

Dodge & Cox reports a significant beneficial ownership of GE Healthcare Technologies Inc. common stock, holding 10.5% of the class.

Dodge & Cox has reported a beneficial ownership of 37,864,164 shares, representing 8.3% of GE Healthcare Technologies Inc.'s common stock, as of June 30, 2026.

Dodge & Cox has reported a beneficial ownership of 31,312,064 shares, representing 6.9% of the outstanding common stock of GE Healthcare Technologies Inc., as of March 31, 2026.

Capital Research Global Investors has filed a Schedule 13G, reporting beneficial ownership of 4.6% of GE HealthCare Technologies Inc. common stock as of March 31, 2026.

Vanguard Capital Management has reported a 7.31% beneficial ownership stake in GE HealthCare Technologies Inc.

The Vanguard Group reports zero beneficial ownership in GE HealthCare Technologies Inc. following an internal realignment.

Investment adviser Dodge & Cox has reported a 6.9% beneficial ownership stake in GE Healthcare Technologies Inc. common stock.

Capital Research Global Investors has reported a 5.5% beneficial ownership stake in GE HealthCare Technologies Inc., holding 24,972,556 shares of common stock.

Dodge & Cox, a prominent investment advisor, has disclosed a 5.1% passive ownership stake in GE Healthcare Technologies Inc. common stock.

Capital Research Global Investors has filed an amended Schedule 13G, reporting a 4.8% beneficial ownership stake in GE HealthCare Technologies Inc. as of May 30, 2025.

Capital Research Global Investors has reported a significant 11.2% beneficial ownership stake in GE HealthCare Technologies Inc., held for ordinary course investment purposes.

The Vanguard Group has filed an amended Schedule 13G, revealing its beneficial ownership of 11.49% of GE HealthCare Technologies Inc.'s common stock as of December 31, 2024.